Comments are not available on this story.
Send questions/comments to the editors.
Related Stories
Latest Articles
Virus_Outbreak_Vaccine_Study_28245
In this Wednesday, April 8, 2020 photo provided by the Center for Pharmaceutical Research, a pharmacy technologist using a biosafety level 2 hood prepares a COVID-19 coronavirus vaccine candidate for testing in Kansas City, Mo. This early safety study, called a Phase 1 trial, is using a vaccine candidate developed by Inovio Pharmaceuticals. (Center for Pharmaceutical Research via AP)